Related references
Note: Only part of the references are listed.Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts
Gregory A. Wellenius et al.
CIRCULATION (2008)
Selective publication of antidepressant trials and its influence on apparent efficacy
Erick H. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Late-life depression
Juergen Unuetzer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression
Xian-Zhang Hu et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Relationship between antidepressants and suicide attempts: An analysis of the veterans health administration data sets
Robert D. Gibbons et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample
Jeffrey B. Kraft et al.
BIOLOGICAL PSYCHIATRY (2007)
Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression
Hyeran Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
The risk of suicide with selective serotonin reuptake inhibitors in the elderly
DN Juurlink et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder
XZ Hu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Antidepressant drug treatment modifies the neural processing of nonconscious threat cues
CJ Harmer et al.
BIOLOGICAL PSYCHIATRY (2006)
Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain
RV Parsey et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder
CJ Hong et al.
PHARMACOGENOMICS JOURNAL (2006)
Aging and clinical pharmacology: Implications for antidepressants
FE Lotrich et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Initial conditions of psychotropic drug response: Studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome
JL Rausch
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Late-onset major depression: clinical and treatment-response variability
HC Driscoll et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2005)
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression
L Pezawas et al.
NATURE NEUROSCIENCE (2005)
Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression
WD Taylor et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Obesity among outpatients with major depressive disorder
GI Papakostas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences
FE Lotrich et al.
PSYCHOPHARMACOLOGY (2005)
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors
K Hirano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
A susceptibility gene for affective disorders and the response of the human amygdala
AR Hariri et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter
A Heinz et al.
NATURE NEUROSCIENCE (2005)
Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression
KRR Krishnan et al.
BIOLOGICAL PSYCHIATRY (2004)
Meta-analysis of serotonin transporter polymorphisms and affective disorders
FE Lotrich et al.
PSYCHIATRIC GENETICS (2004)
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder
LK Durham et al.
PSYCHOPHARMACOLOGY (2004)
Effects of serotonin transporter promoter polymorphisms on serotonin function
GS Smith et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Serum disposition of sertraline, N-desmethylsertraline and paroxetine:: A pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
M Reis et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2004)
Antidepressant pharmacotherapy in the treatment of depression in the very old: A randomized, placebo-controlled trial
SP Roose et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder
PR Szeszko et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression
GM Murphy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits
S Sen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Time course of response to antidepressents in late-life major depression - Therapeutic implications
EM Whyte et al.
DRUGS & AGING (2004)
Paroxetine in major depression:: Correlating plasma concentrations and clinical response
C Normann et al.
PHARMACOPSYCHIATRY (2004)
Serotonin transporter occupancy of five selective serotonin Reuptake inhibitors at different doses:: An [11C]DASB positron emission tomography study
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
Overactive action monitoring in obsessive-compulsive disorder: Evidence from functional magnetic resonance imaging
S Ursu et al.
PSYCHOLOGICAL SCIENCE (2003)
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression
A Szegedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex
NJA van der Wee et al.
NEUROIMAGE (2003)
The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit
EA Lovejoy et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
RH Perlis et al.
BIOLOGICAL PSYCHIATRY (2003)
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment
HS Mayberg
BRITISH MEDICAL BULLETIN (2003)
Evidence that the SSRI dose response in treating major depression should be reassessed: A meta-analysis
CB Baker et al.
DEPRESSION AND ANXIETY (2003)
Epidemiology of late-life mental disorders
CF Hybels et al.
CLINICS IN GERIATRIC MEDICINE (2003)
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype
N Ozaki et al.
MOLECULAR PSYCHIATRY (2003)
Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients
LK Solai et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Serotonin transporter genetic variation and the response of the human amygdala
AR Hariri et al.
SCIENCE (2002)
Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus
AT Du et al.
NEUROLOGY (2002)
Initial conditions of serotonin transporter kinetics and genotype: Influence on SSRI treatment trial outcome
JL Rausch et al.
BIOLOGICAL PSYCHIATRY (2002)
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients
K Yoshida et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression
EM Whyte et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Genetic perspectives on the serotonin transporter
DL Murphy et al.
BRAIN RESEARCH BULLETIN (2001)
Early and late onset depression in old age: different aetiologies, same phenomenology
H Brodaty et al.
JOURNAL OF AFFECTIVE DISORDERS (2001)
Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study
C van Walraven et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
BG Pollock et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders
RM Sapolsky
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Incidence and preventability of adverse drug events in nursing homes
JH Gurwitz et al.
AMERICAN JOURNAL OF MEDICINE (2000)
fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder
CM Adler et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
Platelet activation in depression and effects of sertraline treatment: An open-label study
JH Markovitz et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
BG Pollock et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
A Heinz et al.
BIOLOGICAL PSYCHIATRY (2000)
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene
R Zanardi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Platelet reactivity in depressed patients treated with paroxetine - Preliminary findings
DL Musselman et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: A fluorine MRS study
ME Henry et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants
M Nakamura et al.
MOLECULAR PSYCHIATRY (2000)
Share Paper
